Recommendation by the European Medicines Agency

Friday, December 20th, 2013 by hinrich

Structure of TMC207/R207910

About a year after Bedaquiline (TMC207/R207910) had been approved by the FDA I have seen the news that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the "granting of a conditional marketing authorisation for the medicinal product Sirturo".

Reference: CHMP summary of positive opinion for Sirturo

Posted in Tuberculosis